首页> 外国专利> Polycyclic compounds and methods for targeted degradation of rapidly progressive fibrosarcoma polypeptides

Polycyclic compounds and methods for targeted degradation of rapidly progressive fibrosarcoma polypeptides

机译:多环化合物和急性纤维肉瘤多肽靶向降解的方法

摘要

The present disclosure demonstrates the usefulness of a regulatory protein for raptically accelerated fibrosarcoma (RAF, e.g., c-raf, A-Raf and / or B-Raf)Relating to ulm-l-ptm of bifunctional compounds. In particular, the present disclosure degrades the target proteinA target protein is placed close to the ubiquitin ligase to bring about inhibitionA mouse double minute homologue 2 that binds to the phylepel, celleton, insulators of Apotosis proteins, or each E3 ubiquitin ligase at one end, in one end of RigaA bifunctional compound containing a donor and binding to the target protein RAF at the other endTarget. This disclosure presents extensive pharmacological activity associated with the degradation / inhibition of target proteins. The disease or disorder resulting from the aggregation or accumulation of the target protein or the constitutive activation of the target protein is treated or prevented using the compounds and compositions of the present disclosure.
机译:本公开显示了与双官能化合物的ULM-L-PTM有关的急流加速纤维肉瘤(RAF,例如,C-RAF,A-RAF和/或B-RAF)的调节蛋白的有用性。 特别地,本公开将靶蛋白靶蛋白缩短,靠近泛素连接酶,以引入与Phylepel,Celleton,疏动蛋白质的绝缘体,或一端的每个E3泛素连接酶结合的抑制作用小鼠双粒子2。 在含有供体的Rigaa双官能化合物的一端,并在另一端在另一个末端与靶蛋白RAF结合。 本公开列出了与靶蛋白的降解/抑制相关的广泛的药理学活性。 使用本公开的化合物和组合物治疗或预防由靶蛋白的聚集或累积或靶蛋白的累积产生的疾病或病症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号